KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Medtronic (MDT) Cost of Revenue (2016 - 2026)

Medtronic's Cost of Revenue history spans 13 years, with the latest figure at $3.3 billion for Q1 2026.

  • For Q1 2026, Cost of Revenue rose 17.34% year-over-year to $3.3 billion; the TTM value through Jan 2026 reached $12.5 billion, up 8.14%, while the annual FY2025 figure was $11.6 billion, 3.71% up from the prior year.
  • Cost of Revenue for Q1 2026 was $3.3 billion at Medtronic, up from $3.1 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $3.3 billion in Q1 2026 and bottomed at $2.5 billion in Q1 2022.
  • The 5-year median for Cost of Revenue is $2.8 billion (2025), against an average of $2.8 billion.
  • The largest annual shift saw Cost of Revenue decreased 6.18% in 2022 before it grew 17.34% in 2026.
  • A 5-year view of Cost of Revenue shows it stood at $2.5 billion in 2022, then grew by 8.92% to $2.8 billion in 2023, then grew by 6.7% to $2.9 billion in 2024, then increased by 3.9% to $3.1 billion in 2025, then rose by 6.53% to $3.3 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Cost of Revenue are $3.3 billion (Q1 2026), $3.1 billion (Q4 2025), and $3.0 billion (Q3 2025).